What is Q-Line Biotech IPO?

Q-Line Biotech IPO is a SME IPO. The issue is priced at 326-₹343. The minimum order quantity is 400 Shares. The IPO opens on 21 May, and closes on 25 May. TBA is the registrar for the IPO. The shares are proposed to be listed on SME.

When does the Q-Line Biotech IPO open and close?

The Q-Line Biotech IPO opens on 21 May and closes on 25 May.

Where can I check the live subscription status of the Q-Line Biotech IPO?

You can track the real-time subscription numbers using the links below: https://www.iposcanner.ai/ipo/q-line-biotech-ipo?tab=subscription

What is the issue size of the Q-Line Biotech IPO?

The size of Q-Line Biotech IPO is Total ₹214.48 crore : #Fresh Issue : TBA + #OFS : TBA.

What is the price band of the Q-Line Biotech IPO?

The Q-Line Biotech IPO price band is set between 326-₹343.

What is the minimum investment for the Q-Line Biotech IPO?

The minimum investment for the Q-Line Biotech IPO is ₹2,74,400.

What is the allotment date of the Q-Line Biotech IPO?

The share allotment date of Q-Line Biotech IPO is 26 May.

What is the Q-Line Biotech IPO listing date?

The Q-Line Biotech IPO will be listed on 29 May.

How to check Q-Line Biotech IPO allotment status online?

Follow the steps to check the Q-Line Biotech IPO allotment status online here: https://www.iposcanner.ai/ipo/q-line-biotech-ipo?tab=allotment

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO Calendar GMP Tracker Subscription Status Allotment Status

IPOs

All IPOs Live IPOs Upcoming IPOs Closed IPOs Listed IPOs

Resources

eBooks

Company

Home About Us Privacy Policy Terms of Service

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

Want to stay updated?Subscribe to our newsletter

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO Calendar GMP Tracker Subscription Status Allotment Status

IPOs

All IPOs Live IPOs Upcoming IPOs Closed IPOs Listed IPOs

Resources

eBooks

Company

Home About Us Privacy Policy Terms of Service

About IPO Scanner

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Want to stay updated?Subscribe to our newsletter

Q-Line Biotech

Open Date

May 21, 2026

Close Date

May 25, 2026

listed

Min Investment

₹2,74,400

Lot Size

400 Shares

Issue Size

₹214.48 Cr

Price Range

₹326 - ₹326

Listing Date

May 29, 2026

About Q-Line Biotech

.read-more-text__content { display: block !important; overflow: visible !important; -webkit-line-clamp: unset !important; -webkit-box-orient: initial !important; } .read-more-text__toggle { display: none !important; }

Founded in 2010, Q-Line Biotech Ltd. is involved in the development, manufacture and commercialization of various reagents (kits and POC devices) and consumables and manufacturing, importation, and supply of diagnostic instruments for different healthcare requirements. Q-Line Biotech Ltd. has been providing diagnostic instruments and IVD products for different healthcare requirements since 2013 either directly or via our distributor(s) primarily to diagnostic service organizations, hospitals, and medical colleges. Q-Line Biotech Ltd.'s manufacturing categories comprise indigenous manufacture of reagents including Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics, and Others (POC Devices & Rapid Tests) and supply/ manufacture of in vitro diagnostics (IVD), pathology equipment and devices. As of March 31, 2025, the company employed 313 permanent employees.

Checklist Quality Analysis

Live IPOs

Sotefin Bharat

SME

Open Close16th Jul 2026 - 20th Jul 2026

Issue Size89.76 Cr

Min. Qty600 Shares

Issue Price₹ 178.00

Live IPO

Caliber Mining & Logistics

Mainboard

Open Close17th Jul 2026 - 21st Jul 2026

Issue Size450.00 Cr

Min. Qty35 Shares

Issue Price₹ 402.00

Live IPO

Companies Name	Open - Close	Issue Size	Min. Qty	Issue Price	Apply
Sotefin Bharat SME	16th Jul 2026 - 20th Jul 2026	89.76 Cr	600 Shares	₹ 178.00
Caliber Mining & Logistics Mainboard	17th Jul 2026 - 21st Jul 2026	450.00 Cr	35 Shares	₹ 402.00

See All Live IPOs

Q-Line Biotech IPO - Issue Objectives

The company will utilise ₹93.50 crore for working capital requirement of the business. The company will use ₹90 crore for repayment of borrowings. Part of the IPO proceeds will be used for general corporate purposes and issue expenses

Working capital expenditure

43.6%

Repayment of borrowings

42.06%

General corporate purposes

14.25%

Working capital expenditure

The company will utilise ₹93.50 crore for working capital requirement of the business.

43.60%

Repayment of borrowings

The company will use ₹90 crore for repayment of borrowings.

42.06%

General corporate purposes

Part of the IPO proceeds will be used for general corporate purposes and issue expenses

14.25%

Q-Line Biotech

About Q-Line Biotech

Checklist Quality Analysis

Live IPOs

Grey Market Premium (GMP) Trend

Q-Line Biotech IPO - Issue Objectives

Working capital expenditure

Repayment of borrowings

General corporate purposes

IPO Subscription Status

Financials of Q-Line Biotech

Contact Details

Q-Line Biotech IPO - FAQs